These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 13923263)

  • 1. [Synergism and antagonism of purified phospholipid fractions in thromboplastinogenesis].
    TURPINI R; CIPOLLI PL; MOSSA A
    Boll Soc Ital Biol Sper; 1961 Dec; 37():1320-2. PubMed ID: 13923263
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of blood thromboplastin activity to its total phospholipid content.
    BENTLEY HP; KRIVIT W
    Proc Soc Exp Biol Med; 1962 Mar; 109():530-3. PubMed ID: 13867379
    [No Abstract]   [Full Text] [Related]  

  • 3. The incorporation of P32 in phospholipid fractions in man; a preliminary report.
    CHRISTENSEN S; JENSEN SE; LUNDBAEK K
    Scand J Clin Lab Invest; 1955; 7(3):212-7. PubMed ID: 13298596
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phospholipid fractions in plasma].
    PETERSEN VP
    Nord Med; 1952 Oct; 48(41):1436-7. PubMed ID: 13025845
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of phospholipid fractions in the human erythrocyte.
    FORMIJNE P; POULIE NJ; RODBARD JA
    Clin Chim Acta; 1957 Feb; 2(1):25-34. PubMed ID: 13447211
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic trials with purified phospholipid fractions in coagulation defects].
    MOREO GC; GIBELLI A
    Gazz Int Med Chir; 1962 May; 66():960-73. PubMed ID: 14475901
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical synergism and antagonism of antibiotics].
    Med Hyg (Geneve); 1951 Dec; 9(208):480. PubMed ID: 14899067
    [No Abstract]   [Full Text] [Related]  

  • 8. ANTIBIOTIC synergism and antagonism.
    Can Med Assoc J; 1952 Jun; 66(6):590. PubMed ID: 14945039
    [No Abstract]   [Full Text] [Related]  

  • 9. [Synergism and antagonism of antibiotics].
    ALIN K
    Sven Lakartidn; 1952 May; 49(21):1379-86. PubMed ID: 14958680
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormonal synergism and antagonism in tissue reactions].
    TAUBENHAUS M
    Med Hyg (Geneve); 1951 Oct; 9(205):409-10. PubMed ID: 14890069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of erythrophosphatide as a standard in the determination of blood thromboplastin activity].
    Kharamonenko SS; Rakitianskaia AA; Khomich EN
    Probl Gematol Pereliv Krovi; 1970 Sep; 15(9):38-9. PubMed ID: 5502488
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antagonism and synergism between narcotics and sympathomimetic amines in action upon the central nervous system in warm blooded animals].
    ARBUZOV SI
    Fiziol Zh SSSR Im I M Sechenova; 1950; 36(6):704-11. PubMed ID: 14813316
    [No Abstract]   [Full Text] [Related]  

  • 13. [RESEARCH ON THE INDICES OF CURRENT BIOLOGICAL FLUCTUATION IN MULTIPLE SCLEROSIS. FLUCTUATION OF THE PLASMA PHOSPHOLIPID FRACTIONS IN MULTIPLE SCLEROSIS].
    KETELAER CJ; DELMOTTE P
    Acta Neurol Psychiatr Belg; 1965 Jan; 65():35-56. PubMed ID: 14298781
    [No Abstract]   [Full Text] [Related]  

  • 14. [RESEARCH ON THE ANTIHEPARIN ACTIVITY OF PHOSPHOLIPIDS. I. ACTION OF BLOOD PLATELETS AND THEIR PHOSPHOLIPID SUBSTITUTES ON INHIBITION OF TROMBOPLASTIN FORMATION BY HEPARIN].
    ASCARI E; BARBIERI U; GOBBI F
    Prog Med (Napoli); 1964 Aug; 20():531-5. PubMed ID: 14256537
    [No Abstract]   [Full Text] [Related]  

  • 15. [The increase of plasmatic thromboplastinogenesis in the humoral picture of coronary arteriosclerosis].
    Coccheri S; Fiorentini P; Gennari P
    G Clin Med; 1965 Oct; 46(10):837-63. PubMed ID: 5867361
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of phospholipid-protein fractions in physiopathologic study of chronic liver diseases].
    FASOLI A; BONELLI M
    Minerva Med; 1951 Aug; 42(52-53):204-7. PubMed ID: 14863248
    [No Abstract]   [Full Text] [Related]  

  • 17. Thromboplastin. I. Phospholipid moiety of thromboplastin.
    SLOTTA KH
    Proc Soc Exp Biol Med; 1960 Jan; 103():53-6. PubMed ID: 13831723
    [No Abstract]   [Full Text] [Related]  

  • 18. [CLINICAL AND EXPERIMENTAL OBSERVATIONS ON THE LIVER PROTECTIVE ACTION OF PHOSPHOLIPID FRACTIONS AND ON THEIR INFLUENCE ON LIPID METABOLISM].
    MEONI G
    Clin Ter; 1965 Feb; 32():339-46. PubMed ID: 14307377
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity.
    Mina A; Favaloro EJ; Koutts J
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):203-7. PubMed ID: 22322136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of synthetic phospholipids on the response of the activated partial thromboplastin time to heparin.
    van den Besselaar AM; Neuteboom J; Bertina RM
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):895-903. PubMed ID: 8148482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.